Sartorius Aktiengesellschaft (0NIQ.L)
EUR 178.4
(1.02%)
EUR 178.4
(1.02%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.89 Billion EUR | 106.24% |
| 2022 | 2.37 Billion EUR | 37.09% |
| 2021 | 1.73 Billion EUR | -8.03% |
| 2020 | 1.88 Billion EUR | 85.79% |
| 2019 | 1.01 Billion EUR | 5.69% |
| 2018 | 959.46 Million EUR | 7.14% |
| 2017 | 895.54 Million EUR | 84.3% |
| 2016 | 485.9 Million EUR | 42.31% |
| 2015 | 341.44 Million EUR | -2.22% |
| 2014 | 349.21 Million EUR | -0.3% |
| 2013 | 350.26 Million EUR | 985.66% |
| 2012 | -39.54 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 3.81 Billion EUR | -4.67% |
| 2024 Q2 | 3.99 Billion EUR | -2.38% |
| 2024 Q1 | 4.09 Billion EUR | -16.94% |
| 2023 Q4 | 4.93 Billion EUR | -2.72% |
| 2023 FY | 4.93 Billion EUR | 107.64% |
| 2023 Q1 | 2.45 Billion EUR | 3.24% |
| 2023 Q2 | 2.61 Billion EUR | 6.48% |
| 2023 Q3 | 5.07 Billion EUR | 94.16% |
| 2022 Q3 | 2.34 Billion EUR | 24.66% |
| 2022 Q1 | 1.81 Billion EUR | 4.51% |
| 2022 FY | 2.37 Billion EUR | 37.09% |
| 2022 Q2 | 1.87 Billion EUR | 3.76% |
| 2022 Q4 | 2.37 Billion EUR | 1.42% |
| 2021 Q4 | 1.73 Billion EUR | -2.2% |
| 2021 Q2 | 1.69 Billion EUR | 680.35% |
| 2021 FY | 1.73 Billion EUR | -8.03% |
| 2021 Q1 | 217.64 Million EUR | -88.32% |
| 2021 Q3 | 1.77 Billion EUR | 4.32% |
| 2020 Q4 | 1.86 Billion EUR | 17.15% |
| 2020 Q3 | 1.59 Billion EUR | -3.59% |
| 2020 FY | 1.88 Billion EUR | 85.79% |
| 2020 Q1 | 934.5 Million EUR | -6.12% |
| 2020 Q2 | 1.65 Billion EUR | 76.59% |
| 2019 Q3 | 998.7 Million EUR | -2.06% |
| 2019 FY | 1.01 Billion EUR | 5.69% |
| 2019 Q4 | 995.44 Million EUR | -0.33% |
| 2019 Q2 | 1.01 Billion EUR | 6.82% |
| 2019 Q1 | 954.6 Million EUR | -0.23% |
| 2018 Q2 | 952.5 Million EUR | 6.14% |
| 2018 Q3 | 937.8 Million EUR | -1.54% |
| 2018 Q1 | 897.39 Million EUR | 0.54% |
| 2018 FY | 959.46 Million EUR | 7.14% |
| 2018 Q4 | 956.79 Million EUR | 2.03% |
| 2017 Q2 | 917 Million EUR | 15.58% |
| 2017 FY | 895.54 Million EUR | 84.3% |
| 2017 Q4 | 892.54 Million EUR | -1.76% |
| 2017 Q3 | 908.5 Million EUR | -0.93% |
| 2017 Q1 | 793.4 Million EUR | 64.3% |
| 2016 Q1 | 354.2 Million EUR | 3.73% |
| 2016 Q4 | 482.88 Million EUR | -2.68% |
| 2016 Q3 | 496.2 Million EUR | 3.07% |
| 2016 Q2 | 481.4 Million EUR | 35.91% |
| 2016 FY | 485.9 Million EUR | 42.31% |
| 2015 Q1 | 267.39 Million EUR | -23.43% |
| 2015 FY | 341.44 Million EUR | -2.22% |
| 2015 Q4 | 341.44 Million EUR | 6.07% |
| 2015 Q3 | 321.9 Million EUR | 6.59% |
| 2015 Q2 | 302 Million EUR | 12.94% |
| 2014 Q2 | 375 Million EUR | 8.04% |
| 2014 Q1 | 347.1 Million EUR | -0.91% |
| 2014 FY | 349.21 Million EUR | -0.3% |
| 2014 Q4 | 349.21 Million EUR | -5.0% |
| 2014 Q3 | 367.6 Million EUR | -1.97% |
| 2013 Q1 | -37 Million EUR | 6.45% |
| 2013 Q3 | 324.7 Million EUR | -5.36% |
| 2013 Q4 | 350.26 Million EUR | 7.87% |
| 2013 Q2 | 343.1 Million EUR | 1027.3% |
| 2013 FY | 350.26 Million EUR | 985.66% |
| 2012 Q4 | -39.54 Million EUR | 0.0% |
| 2012 FY | -39.54 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cegedim SA | 238.49 Million EUR | -1954.081% |
| Guerbet SA | 313.3 Million EUR | -1463.6% |
| Nexus AG | 2.81 Million EUR | -174176.058% |
| Bastide Le Confort Médical SA | 333.35 Million EUR | -1369.588% |
| Revenio Group Oyj | -2.8 Million EUR | 175060.714% |
| Drägerwerk AG & Co. KGaA | 199.42 Million EUR | -2356.488% |
| LNA Santé SA | 810.5 Million EUR | -504.428% |
| Siemens Healthineers AG | -1 Billion EUR | 585.52% |
| Medios AG | -53.89 Million EUR | 9190.217% |
| Equasens Société anonyme | 50.84 Million EUR | -9535.727% |
| Stratec SE | 107.83 Million EUR | -4442.791% |